Research Nester published a report titled “Latin America Interventional Cardiology Market: Demand Analysis & Opportunity Outlook 2030” which delivers detailed overview of the Latin America interventional cardiology market in terms of market segmentation by devices, application and by end user.

Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.

Driven by the increasing incidences of cardiovascular diseases and growing accessibility to advanced healthcare, the Latin America interventional cardiology market is estimated to witness significant growth in upcoming years. The Latin America interventional cardiology market accounted for a market value of USD 717.32 million in 2019 and is expected to grow at a CAGR of 8.48% over the forecast period of 2021-2030. The market is segmented on the basis of application into coronary artery disease, peripheral artery disease, neurovascular disease and others, out of which, coronary artery disease accounted for a market share of 44.56% in 2019 and expected to grow by a significant CAGR over the forecast period. The most prevalent form of heart disease is known as coronary artery disease. It happens when the arteries that supply blood to the heart gets blocked. Furthermore, the growing prevalence of the disease has generated an increase in demand for devices and treatments which can reduce complications and improve the quality of life. The segment peripheral artery disease is a common circulatory disorder that narrows the arteries and reduces blood flow to the limbs, and therefore it is further anticipated to raise the demand for interventional cardiology products.

Increasing Incidences of Cardiovascular Diseases (CVD) And Increasing Accessibility to Advanced Healthcare to Drive the Market Growth

Over the past few years, the interventional cardiology industry has seen substantial growth on account of the growing prevalence of cardiovascular disorders in countries such as Brazil, Mexico, Argentina and others. The elevated risk of cardiovascular disease is attributed to the habits including smoking, consumption of alcohol, and poor diet. Owing to an increasing number of people opting for creative surgical treatments that shorten the admission time of patients and mitigate the after effects of operations, Latin America has seen an increasing demand for instruments used in percutaneous coronary intervention. This has resulted in the government investing in improving the healthcare infrastructure to address the growing demands and minimize disease progression. During the forecast period, such factors are projected to drive the growth of the Latin American interventional cardiology market.

However, lack of skilled cardiovascular surgeons to perform interventional cardiology procedures and high risk of infection in patients after the procedure are estimated to act as barriers to the growth of the Latin America interventional cardiology market during the forecast period.

This report also provides the existing competitive scenario of some of the key players of the Latin America interventional cardiology market which includes company profiling of Boston Scientific Corporation (NYSE: BSX), Merit Medical Systems (NASDAQ: MMSI), Biosensors International Group, Ltd., Terumo Europe NV, Medtronic (NYSE: MDT), Cardinal Health (Cordis), BIOTRONIK SE & Co KG, and others. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the Latin America interventional cardiology market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.